PBPIA
IOBT

Pivotal bioVenture Partners Investment Advisor’s IO Biotech IOBT Stock Holding History

Pivotal bioVenture Partners Investment Advisor’s Portfolio IOBT Stock Details IOBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-864,197
Closed -$1.2M – 12
2025
Q2 		$1.2M Hold
864,197
– – 0.74% 10
2025
Q1 		$942K Hold
864,197
– – 0.76% 10
2024
Q4 		$795K Hold
864,197
– – 0.54% 11
2024
Q3 		$907K Hold
864,197
– – 0.54% 11
2024
Q2 		$1.01M Hold
864,197
– – 0.78% 9
2024
Q1 		$1.5M Hold
864,197
– – 0.96% 10
2023
Q4 		$1.62M Hold
864,197
– – 0.41% 12
2023
Q3 		$1.22M Buy
+864,197
New +$1.52M 0.49% 12

Other funds holding IOBT

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Pivotal bioVenture Partners Investment Advisor's IOBT Position: Q3 2025 in Review

Pivotal bioVenture Partners Investment Advisor sold out of IO Biotech (IOBT) in Q3 2025, closing a stake of 864,197 shares — an estimated $1.2M sold.

Pivotal bioVenture Partners Investment Advisor first reported a position in IOBT in Q3 2023 and held it in 8 quarters. The position peaked at $1.62M in Q4 2023. 21 funds tracked by Wall St. Rank hold IOBT as of Q3 2025.

  • Pivotal bioVenture Partners Investment Advisor reported no remaining IO Biotech position as of Q3 2025 after selling out during the quarter.
  • Pivotal bioVenture Partners Investment Advisor sold 864,197 IO Biotech shares in Q3 2025, an estimated $1.2M.
  • Pivotal bioVenture Partners Investment Advisor first reported a position in IO Biotech in Q3 2023 and held it in 8 quarters.
  • Pivotal bioVenture Partners Investment Advisor's IO Biotech position peaked at $1.62M in Q4 2023.
  • 21 funds tracked by Wall St. Rank held IO Biotech as of Q3 2025.

Based on Pivotal bioVenture Partners Investment Advisor's 13F filing for Q3 2025, filed 13 Nov 2025.